Radiolabeling and formulation for scale up of
Abstract:
The present disclosure relates to methods to create a robust procedure capable of supplying commercial quantities of a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients.
Public/Granted literature
Information query
Patent Agency Ranking
0/0